Kihyun Kım
About
Kihyun Kım is a scholar working on Hematology, Oncology and Molecular Biology.
According to data from OpenAlex, Kihyun Kım has authored 403 papers receiving a total of 8.1k indexed citations (citations by other indexed papers that have themselves been cited), including 199 papers in Hematology, 160 papers in Oncology and 146 papers in Molecular Biology. Recurrent topics in Kihyun Kım's work include Multiple Myeloma Research and Treatments (157 papers), Protein Degradation and Inhibitors (66 papers) and Lymphoma Diagnosis and Treatment (54 papers). Kihyun Kım is often cited by papers focused on Multiple Myeloma Research and Treatments (157 papers), Protein Degradation and Inhibitors (66 papers) and Lymphoma Diagnosis and Treatment (54 papers). Kihyun Kım collaborates with scholars based in South Korea, United States and Japan. Kihyun Kım's co-authors include Won Seog Kim, Chul Won Jung, Young Hyeh Ko, Keunchil Park, Seok Jin Kim, Benjamin Chu, Benjamin S. Hsiao, Michael Hadjiargyrou, Y.K. Luu and Won Ki Kang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.
In The Last Decade
Kihyun Kım
359 papers receiving 7.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Kihyun Kım South Korea | 42 | 3.3k | 2.3k | 2.3k | 2.2k | 1.1k | 403 | 8.1k | ||
| Ofer Shpilberg Israel | 46 | 3.7k 1.1× | 1.9k 0.8× | 3.3k 1.4× | 3.4k 1.5× | 1.5k 1.3× | 261 | 9.2k | ||
| Anne Janin France | 58 | 2.5k 0.8× | 3.6k 1.6× | 1.5k 0.7× | 1.3k 0.6× | 3.1k 2.8× | 333 | 11.4k | ||
| Mario Petrini Italy | 39 | 2.1k 0.6× | 1.4k 0.6× | 976 0.4× | 1.3k 0.6× | 831 0.7× | 319 | 7.2k | ||
| Dominique Bron Belgium | 56 | 3.8k 1.2× | 2.6k 1.1× | 1.9k 0.8× | 3.4k 1.5× | 2.2k 2.0× | 304 | 11.7k | ||
| Franca Fagioli Italy | 54 | 2.1k 0.6× | 2.7k 1.2× | 3.2k 1.4× | 729 0.3× | 1.6k 1.4× | 394 | 10.9k | ||
| Giorgio La Nasa Italy | 45 | 1.3k 0.4× | 1.8k 0.8× | 2.3k 1.0× | 866 0.4× | 899 0.8× | 275 | 6.7k | ||
| Jeffrey R. Sawyer United States | 46 | 2.1k 0.6× | 4.9k 2.1× | 4.3k 1.9× | 801 0.4× | 338 0.3× | 277 | 9.9k | ||
| Mitchell S. Cairo United States | 61 | 4.5k 1.4× | 2.7k 1.2× | 4.8k 2.1× | 3.3k 1.5× | 3.0k 2.6× | 507 | 14.9k | ||
| Larry W. Moreland United States | 59 | 1.5k 0.5× | 1.8k 0.8× | 5.0k 2.2× | 2.3k 1.0× | 4.7k 4.2× | 291 | 18.9k | ||
| Michael Wang United States | 62 | 8.2k 2.4× | 5.9k 2.5× | 4.0k 1.8× | 4.8k 2.2× | 2.6k 2.3× | 554 | 16.3k |
Countries citing papers authored by Kihyun Kım
Since
Specialization
Citations
This map shows the geographic impact of Kihyun Kım's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kihyun Kım with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kihyun Kım more than expected).
Fields of papers citing papers by Kihyun Kım
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kihyun Kım. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kihyun Kım. The network helps show where Kihyun Kım may publish in the future.
Co-authorship network of co-authors of Kihyun Kım
This figure shows the co-authorship network connecting the top 25 collaborators of Kihyun Kım. A scholar is included among the top collaborators of Kihyun Kım based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kihyun Kım. Kihyun Kım is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Fu, Weijun, Soo‐Mee Bang, Honghui Huang, et al.. (2024). Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS Study. Annals of Hematology. 104(1). 515–525.
2.
Jung, Sung‐Hoon, Je‐Jung Lee, Young Rok, et al.. (2024). Comparative analysis of single versus tandem autologous stem cell transplantation in patients with multiple myeloma in Korea: the KMM2102 study. Scientific Reports. 14(1). 24325–24325.
3.
Cohen, Yaël C., Daniel Morillo, Moshe E. Gatt, et al.. (2023). POSTER: MM-164 First Results From the RedirecTT-1 Study With Teclistamab (Tec) + Talquetamab (Tal) Simultaneously Targeting BCMA and GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma (RRMM). Clinical Lymphoma Myeloma & Leukemia. 23. S226–S226.
4.
Cohen, Yaël C., Daniel Morillo, Moshe E. Gatt, et al.. (2023). MM-164 First Results From the RedirecTT-1 Study With Teclistamab (Tec) + Talquetamab (Tal) Simultaneously Targeting BCMA and GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma (RRMM). Clinical Lymphoma Myeloma & Leukemia. 23. S478–S479.
5.
Park, Yong‐Jin, Darae Kim, Jin‐Oh Choi, et al.. (2023). Direct comparison of diagnostic and clinical values between Tc-99 m DPD and Tc-99 m PYP scintigraphy in patients with cardiac amyloidosis. BMC Medical Imaging. 23(1). 92–92.
6.
Jung, Sung‐Hoon, Kihyun Kım, Jae Hoon Lee, et al.. (2022). Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma. Annals of Hematology. 101(6). 1217–1226.
7.
Yoo, Kwai Han, Dok Hyun Yoon, Hye Jin Kang, et al.. (2021). Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features. Current Problems in Cancer. 46(1). 100788–100788.
8.
Jhun, Byung Woo, Hee Jae Huh, Chul Won Jung, et al.. (2021). Is the New Interferon-Gamma Releasing Assay Beneficial for the Diagnosis of Latent and Active Mycobacterium tuberculosis Infections in Tertiary Care Setting?. Journal of Clinical Medicine. 10(7). 1376–1376.
9.
Jo, Jae‐Cheol, Yoo Jin Lee, Sang Eun Yoon, et al.. (2021). Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT. Blood Cancer Journal. 11(12). 190–190.
10.
Ryu, Daeun, Seok Jin Kim, Yourae Hong, et al.. (2019). Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion. Clinical Cancer Research. 26(4). 935–944.
11.
Jung, Sung‐Hoon, Je‐Jung Lee, Je‐Jung Lee, et al.. (2018). Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150). Biology of Blood and Marrow Transplantation. 24(5). 923–929.
12.
Kım, Kihyun, et al.. (2014). The Effect of Poverty on Children's Development －Role of Cumulative Risk Factors－. Journal of the Korean society of child welfare. 185–216.
13.
Kım, Kihyun, Kihyun Kım, Mark Lee, et al.. (2013). Observational Study Of VMP (Bortezomib, melphalan, prednisolone) Regimen For Newly Diagnosed Korean Myeloma Patients Who Are Not Eligible For Transplantation. Blood. 122(21). 5379–5379.
14.
Baz, Rachid, Hui‐Yi Lin, Sung‐Soo Yoon, et al.. (2013). Response Adapted Lenalidomide Based Therapy For Newly Diagnosed (ND) Standard Risk Older Adults With Multiple Myeloma (MM): An International Collaboration. Blood. 122(21). 3201–3201.
15.
Kim, Jae Yop, et al.. (2010). Analysis on the Relationships Between Adolescent’s Use of Internet Pornography and Sexual Violence - Based on the Control Theory -. Journal of the Korean society of child welfare. 79–106.
16.
Kım, Kihyun, et al.. (2009). A Long-term Study on Ozone Concentration Profiles in Roadside and Residential Locations in Seoul, Korea. 12(3). 204–220.
17.
Moon, Joon Ho, Sang Kyun Sohn, Myung-Hoon Lee, et al.. (2009). BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients. Leukemia Research. 34(2). 166–172.
18.
Kım, Kihyun, et al.. (2009). Measuring the Compatibility Factors in Mobile Entertainment Service Adoption. Journal of Computer Information Systems. 50(1). 141–148.
19.
Kım, Kihyun, et al.. (2008). Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patients. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 453(2). 155–163.
20.
Park, Sarah, Jeeyun Lee, Young Hyeh Ko, et al.. (2007). The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood. 110(3). 972–978.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ofer Shpilberg Breakdown of academic impact, for papers by Anne Janin Breakdown of academic impact, for papers by Mario Petrini Breakdown of academic impact, for papers by Dominique Bron Breakdown of academic impact, for papers by Franca Fagioli Breakdown of academic impact, for papers by Giorgio La Nasa Breakdown of academic impact, for papers by Jeffrey R. Sawyer Breakdown of academic impact, for papers by Mitchell S. Cairo Breakdown of academic impact, for papers by Larry W. Moreland Breakdown of academic impact, for papers by Michael Wang